Revolution Medicines shares soar 85% in trading debut after IPO priced at top end of range - (MarketWatch via NewsPoints Desk)

  • Shares of Revolution Medicines gained 85% Thursday in their trading debut, after underwriters priced the initial public offering at the top end of a revised range, reported MarketWatch.

  • The clinical-stage oncology company sold 14 million shares priced at $17 each to raise $238 million. The deal was upsized from an earlier plan to offer 10 million shares priced at $14 to $16 each.

To read more NewsPoints articles, click here.